FABP3 and congestive heart failure: Thus, H-FABP is becoming an effective biomarker for the diagnosis and assessment of cardiovascular diseases, such as congestive heart failure (CHF), unstable heart pectoris (UAP), acute myocardial infarction (AMI), dilated cardiomyopathy (DCM), and many other diseases [19].